Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come
P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - Elsevier
Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
Design and functionalization strategies for multifunctional nanocarriers (eg, nanoparticles,
micelles, polymersomes) based on biodegradable/biocompatible polymers intended to be …
micelles, polymersomes) based on biodegradable/biocompatible polymers intended to be …
Cancer active targeting by nanoparticles: a comprehensive review of literature
Purpose Cancer is one of the leading causes of death, and thus, the scientific community
has but great efforts to improve cancer management. Among the major challenges in cancer …
has but great efforts to improve cancer management. Among the major challenges in cancer …
[HTML][HTML] Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
The concept of PLGA-lipid hybrid nanoparticles arose as a motivation for develo** drug
delivery systems with versatile physical and chemical properties, unequivocal therapeutic …
delivery systems with versatile physical and chemical properties, unequivocal therapeutic …
Effect of gold nanoparticle aggregation on cell uptake and toxicity
Aggregation appears to be a ubiquitous phenomenon among all nanoparticles and its
influence in mediating cellular uptake and interactions remain unclear. Here we developed …
influence in mediating cellular uptake and interactions remain unclear. Here we developed …
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review
Lipid–polymer hybrid nanoparticles (LPNs) are core–shell nanoparticle structures
comprising polymer cores and lipid/lipid–PEG shells, which exhibit complementary …
comprising polymer cores and lipid/lipid–PEG shells, which exhibit complementary …
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
BACKGROUND: Traditional cancer therapy can be successful in destroying tumors, but can
also cause dangerous side effects. Therefore, many targeted therapies are in development …
also cause dangerous side effects. Therefore, many targeted therapies are in development …
Vitamin E TPGS as a molecular biomaterial for drug delivery
Z Zhang, S Tan, SS Feng - Biomaterials, 2012 - Elsevier
d-α-tocopheryl polyethylene glycol succinate (Vitamin E TPGS, or simply TPGS) is a water-
soluble derivative of natural Vitamin E, which is formed by esterification of Vitamin E …
soluble derivative of natural Vitamin E, which is formed by esterification of Vitamin E …
Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
A Mukherjee, AK Waters, P Kalyan… - International journal …, 2019 - Taylor & Francis
Lipid–polymer hybrid nanoparticles (LPHNPs) are next-generation core–shell
nanostructures, conceptually derived from both liposome and polymeric nanoparticles …
nanostructures, conceptually derived from both liposome and polymeric nanoparticles …
Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications
Abstract Poly (lactic‐co‐glycolic) acid (PLGA) is one of the most versatile biomedical
polymers, already approved by regulatory authorities to be used in human research and …
polymers, already approved by regulatory authorities to be used in human research and …